chrisvoncsefalvay/vaers-outcomes huggingface dataset:
1/26/2021 0230 pain at the injection site, body aches, increased heart rate, fever, and extreme tactile, auditory, and visual sensitivity.  Symptoms resolved 1/27/2021 at 0500.
Inability to walk, loss of feeling in hands and feet. Loss of feeling of hot/cold in hands and feet with inability to hold items in hands. Sharp, shock-like currents in feet and legs and numbness in toes.
This spontaneous report as received from a medical assistant refers to 11 month old patient of unknown gender. On an unknown date in April 2014, between 12-APR-2014 and 24-APR-2014, the patient was vaccinated with a dose of VARIVAX lot # J012210, expiry 28-SEP-2015 ("VFC" stock), 0.5 ml, once, intramuscular. The medical assistant stated there was a power outage on 12-APR-2014 and the VARIVAX doses from the freezer needed to be transported to unspecified hospital for proper storage. She stated VARIVAX was exposed to 46F for 1 hour, at worst. There were no prior excursions. There was a site visit from local health department on an unspecified date. No adverse effects reported. This is one of several reports received from the same reporter. Additional information has been requested.
T 36 C (102.2 F); vesicular rash X 3 now discolored approx 1-2 cm. Fever today 100.2 tympanic. Mother reports rash worstening. PHN observed generalized red pinpoint rash in groin; on abdomen on back on legs. Day 10 after vaccines mother concerned child with decreased fluid intake and decreased urine out put. She has not treated fever or pushed po fluids. Child very weak but verbally and physically responsive to PHN testing temperature tympanically. Other significant history; child started vaccines June 11 2016 when returned from abroad. Child normally very active and went to playground in local mall after receiving 2nd set of vaccines on 9/14/15. Mother reports 2 lb weight loss. PHN assessed probable dehydtation. PHN reported to NP. Mother instructed to administer childrens Tylenol q 6 hours and push po fluid such as water juice; pedialyte. If no improvement despite this mother instructed to bring child to ER since child does not have an established MD. PHN will follow up with T/C this PM and 9/25/15 AM. 9/24/15 5 PM mother reports child drank better voided x3 and has no fever. 9/25/15 mother reports child awake and crying all night; voided X 1 and she was unable to give him Tylenol or increase his fluid intake. PHN instructed mother to take child to ER for fluids. NP and Office manager notified. Incident report and VAERS filed. PHN request mother call with update.
pt came in for booster dose, Wrong medication was administered, 12 and up version of covid vaccine was given 0.2ml instead of 5-11 dose
Patient received both vaccines at the same time on 10/2/23. Developed bilateral hand numbness on 10/10/23 and it became more persistent the next day. She started to experience some weakness affecting both upper extremities and having foot numbness that progressed to bilateral leg weakness. She was having difficulty ambulating and was using her husbands walker but the weakness progressively worsened.  No issues with vision, no trouble with swallowing, no SOB. Had a mild headache and went to the urgent care on 10/12/23 and was given a shot of ketorolac. Her symptoms became worse where she was unable to stand or walk by herself so she went to the emergency department. Tests determined that she was suffering from Guillain-Barre syndrome
Patient came in feeling nervous and decided to receive his first Pfizer Covid19 shot. The shot was administered with no issues about 15 minutes later when checking on the patient he stated he felt groggy/spacey. I asked him if he has eaten today which he had. He is not diabetic and has been drinking >>1 gallon of water per day for the past month. I asked him if he would allow me to check his blood pressure, he had a pressure of 145/100 and pulse of 145. He stated that is abnormal for him as he has had multiple brain aneurysm and is on medication to keep his pressure and pulse low. I asked him to try to relax for 5 minutes before repeating the test which resulted in a bp of 168/100 and hr of 145 at this point I offered to take him to the ER and he said he is in a condition he is comfortable driving himself.
Week after I had gotten the COVID-19 I had symptoms of books on my vagina and went to the doctors to get meds. Now, to this day I get boils that pop up down on my vagina and no sooner they pop up they go away and either way it hurts.
Patient started to feel "spacey, cloudy" in her head  about five minutes after receiving the vaccination.  She stated she s unable to describe the feeling.  Patient taken to the observation area for eval.  BP 113/67 HR 88 oxygen sat 98% room air.  Once in the observation area she complained of a headache "4/10".  She was given cold water.    1315 patient states that her symptoms have resolved,  headache is still there but she is wanting to take tylenol when she gets home.  1323 patient released from observation and escorted to the exit via wheelchair and staff member
I caught COVID after receiving my vaccine. I started off first having severe headaches. 2 says later I had postnasal drip and a raw feeling in my throat. My throat was also sore. Then I started getting severe body aches. At 2am, I got out of bed to take my temperature because I was in pain. I had a fever. By 4am, I was having difficulty breathing. By 9am, I called my doctor and went to the hospital on January 3, 2022, at a local hospital. My heart rate was consistently about 139 beats per minute. I received three infusions of remdesivir. I was discharged on January 6, 2022. I was extremely weak, and I had labored breathing. I couldn't have a conversation without losing my breath. I was absolutely exhausted. When I thought I was improving I actually took a turn for the worse. I was prescribed a 6-day dose of steroids on January 7, 2022. I went to see my pulmonologists on January 27, 2022, because my breathing got worse again. My oxygen was dropping down to 83%-86% when walking. He listened to my lungs and said that I wasn't passing air through my lungs. I was prescribed a 14-day dose of prednisone. I saw him again on February 8, 2022. He was really surprised at how clear my lungs were. I continued to improve from then up until last week. The past last week I started to feel more like myself because I was able move around without being short of breath.
Moderna Vaccine wad administered after the beyond use date at refrigerated temperature. BUD 10/01/2021
This spontaneous case was reported by a consumer and describes the occurrence of INJECTION SITE JOINT ERYTHEMA (Huge Red Raised Injection Site (size of orange)), ERYTHEMA (Red Injection Site), PUSTULE (whelk like lesion comes and goes), PRURITUS (The Second time the Injection Site reaction Happened it was Itchy) and PYREXIA (Fever to the touch Injection Site) in an 81-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 041L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below. Concurrent medical conditions included Asthma and Hypertension. Concomitant products included CETIRIZINE for Asthma. On 18-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 20-Jan-2021, the patient experienced INJECTION SITE JOINT ERYTHEMA (Huge Red Raised Injection Site (size of orange)), ERYTHEMA (Red Injection Site), PUSTULE (whelk like lesion comes and goes) and PYREXIA (Fever to the touch Injection Site). On 24-Jan-2021, the patient experienced PRURITUS (The Second time the Injection Site reaction Happened it was Itchy). On 02-Feb-2021, the patient experienced INJECTION SITE ERYTHEMA (Injection Site Redness still going on). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE, ZINC OXIDE (BENADRYL LOTION N) (topical) for Itching, at a dose of 1 dosage form. At the time of the report, INJECTION SITE JOINT ERYTHEMA (Huge Red Raised Injection Site (size of orange)), ERYTHEMA (Red Injection Site), PUSTULE (whelk like lesion comes and goes), PRURITUS (The Second time the Injection Site reaction Happened it was Itchy), PYREXIA (Fever to the touch Injection Site) and INJECTION SITE ERYTHEMA (Injection Site Redness still going on) outcome was unknown. Not Provided. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Pt recvd 3 doses of Engerix-B & tested neg for antibodies; plan to booster;
Patient states she had unusual redness, bruising and swelling since her shot, received 3 days ago. Pain is 6 on scale of 10 and is localized  to injection site- No pain or numbness in rest of arm. patient states injection hurts worse that Anthrax vaccine received.
BONE PAIN; FEVER; HEADACHE; This spontaneous report received from a patient concerned a 54 year old male. The patient's height, and weight were not reported. The patient's concurrent conditions included non smoker, and abstains from alcohol, and the patient had no known allergies.  The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 1808982, expiry: UNKNOWN) dose was not reported, administered on 28-APR-2021 11:00:00 for prophylactic vaccination. No concomitant medications were reported.  On 29-APR-2021, the subject experienced bone pain. On 29-APR-2021, the subject experienced fever. On 29-APR-2021, the subject experienced headache. Laboratory data (dates unspecified) included: Fever (NR: not provided) Not measured. Treatment medications (dates unspecified) included: paracetamol. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from bone pain, fever, and headache. This report was non-serious. This case, from the same reporter is linked to 20210459729 and 20210459724.
The pt developed red blotchy macular rash on face, faded when settled down then increased in color when cried again.
Flushing, clammy skin, coughing, wheezing, dyspnea, voice changes, patient stated she felt like - "I can breathe in but I can't breathe out"
common flu symptoms; shivering; This case was reported by a pharmacist via call center representative and described the occurrence of flu symptoms in an unspecified number of the patients who received Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received Shingrix at an unknown dose. On an unknown date, unknown after receiving Shingrix, the patient experienced flu symptoms and shivering. On an unknown date, the outcome of the flu symptoms and shivering were unknown.   It was unknown if the reporter considered the flu symptoms and shivering to be related to Shingrix.  Additional details were provided as follows: The age at vaccination was not reported. The age group was not reported but it was selected as adult as per the vaccine indication. The pharmacist reported that the many patients in her practice experience common flu symptoms, such as shivering, after getting the Shingrix vaccine. The reporter was unable to provide specific information related to specific patients and vaccine.
Patient said her arm at the injection site swelled up that night that she got the shot and it hurt. She experienced the arm swollen and hurting for about three days. She said that night she was feeling dizzy, chilled, had a headache, nausea, and ached all over. Three days later she called the pharmacy and spoke to another pharmacist and she was told that these are possible side effects and that if symptoms continue to contact her dr. Six days later she went to her dr. The dr called and told patient to go to ER if symptoms continue and for me to report to VAERS.
patient came back to pharmacy one day after receiving her second Moderna covid vaccine. She reported injection site pain, swelling, redness. No fever, no problems breathing.
I developed a rash (red splotchy marks on my skin) that started localized under my arms in the arm pit region. I noticed it during my daily shower on 4/9. It was very itchy and then overnight it seemed to spread to other parts of my body including my back, back of my legs behind my knee, upper groin area, down to the tops of my feet and even the palms of my hand were very itchy as well as between my fingers. Basically only my face/head/neck were NOT affected.   Over the next couple of days the rash continued to subside temporarily but then with itching, it would return.   Finally, I am not sure if it is related but I had heart burn like symptoms over night on 4/9 and again on 4/10. That could be a coincidence but I only suffer from heart burn about once every 3 months so it seems strange that I would have it on back to back nights.   This all occurred just over 2 weeks from my vaccination so I thought it might have another cause but I could not figure out another possible explanation for it. I also took pictures if that would be helpful to see.
Low grade fever for 2 weeks, Fatigue for 2 weeks, severe generalized myalgia for over 4 weeks
Immune thrombocytopenic purpura following Pfizer-BioNTech COVID-19 Vaccine with presenting features of petechiae, gum bleeding, epistaxis, and subconjunctival hemorrhage; This is a literature report for the following literature source(s).  A 67-year-old female patient received BNT162b2 (BNT162B2), as dose 2, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history included: "HTN" (unspecified if ongoing); "DM" (unspecified if ongoing); "Hypothyroidism" (unspecified if ongoing); "Depression" (unspecified if ongoing); "B12 deficiency" (unspecified if ongoing); "Headaches" (unspecified if ongoing). The patient's concomitant medications were not reported. Vaccination history included: Bnt162b2 (DOSE 1; symptoms 14 days after the first dose), for COVID-19 immunization, reaction(s): "Symptoms". The following information was reported: IMMUNE THROMBOCYTOPENIA (hospitalization, medically significant), 2 days after the suspect product(s) administration, outcome "unknown", described as "Immune thrombocytopenic purpura following Pfizer-BioNTech COVID-19 Vaccine with presenting features of petechiae, gum bleeding, epistaxis, and subconjunctival hemorrhage". The patient was hospitalized for immune thrombocytopenia (hospitalization duration: 14 day(s)). The patient underwent the following laboratory tests and procedures: Platelet count: 3 x10 3/mm3. Therapeutic measures were taken as a result of immune thrombocytopenia including prednisone, IVIG, platelet, ACA, rituximab, and TPO-RA. Per clinical course, the patient was discharged on day 14 (received rituximab and TPO-RA outpatient).; Sender's Comments: Based on the close temporal relationship, the association between the event immune thrombocytopenia with BNT162b2 can not be fully excluded.  The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to regulatory authorities, Ethics Committees, and Investigators, as appropriate.
Reserved Varivax on 8-5-08. We saw patient in the office on 8-7-08. She had marked swelling (3 inches x 5 inches), erythema and pain in the right arm where vaccine was given. Pain began during the night 8/5/08-08/06/08.
A 44 year old male experienced myalgia, arthralgia, or bursitis after receiving his second immunization of RabAvert for preexposure prophylaxis. The pt received his first dose of RabAvert (1ml, IM) on 10May04, followed by a second dose (1ml, IM) on 17May04. The pt's medical history was non-contributory. He had no known drug allergies and was not on any concomitant medications. On 10May04, the pt received his first vaccination with RabAvert and tolerated without any difficulties. On 17May04, one hour and twenty minutes and administration of the second dose of RabAvert, the pt complained of pain in his neck, right shoulder, and upper spine area. The pt was rated as a 2 out of 10 on a pain scale (1 least painful, 10 most painful). On the evening of 17May04, the pt had increased to a 10 out of 10. On 20May04, the pt was medically assessed and was prescribed Ibuprofen for treatment. At this time, the pt had improved to 2 out of 10 on the pain scale. The pt's physician felt that the pain was myalgia, arthralgia, or bursitis due to RabAvert.
itchy eyes, mouth, ears, blisters in mouth, tongue was neon red and cracked, the redness went away in a few hours but other symptoms continued until next day, took 20mg of prednisone next morning instead of usual 10mg
"A mother reported that her 2 month old daughter, post vax, the next day, she developed diarrhea. Three days later, she had a blood tinged stool. The physician reportedly suspects milk protein allergy."
This spontaneous report was received from a medical assistant, referring to a patient of an unknown age and gender. Information about the patient's medical history, current conditions, drug allergies or reactions were not provided. On 28-JAN-2019, the patient was vaccinated with one dose of expired (recombinant human albumin (rHA)) PROQUAD for prophylaxis, lot # N020619 and expiration date 22-JAN-2019 (dose, route of administration and anatomical location were not reported). It also was reported that the sterile diluent that was used to reconstitute the PROQUAD was not expired. No adverse effects were reported in the patient.
Case number PHEH2014US020848, is an initial spontaneous report from a consumer (also patient) received on 15 OCT 2014. This report refers to a 60-year-old male patient. Past medical history and concomitant medication was reported. He was vaccinated with FLUCELVAX (batch number: not reported) intramuscularly on 14 OCT 2014. On the same day within hours after vaccination, he experienced stiff and achy neck. The stiffness and achiness had got progressive worse over 24 hour period despite treatment with Asprin  and hearing pad. The final outcome of the events was unknown. Seriousness and causality was not reported.
Had a spike in blood pressure (194/100); Increased heart rate; Toe injury/Minor bruising; Trouble sleeping; Sleeping pattern has changed; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of HYPERTENSIVE CRISIS (Had a spike in blood pressure (194/100)) in a 76-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 001B21A and 006M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included Insomnia. Concurrent medical conditions included White coat hypertension. Concomitant products included CALCIUM for Calcium supplementation, MELATONIN for an unknown indication.   On 14-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 14-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. In April 2021, the patient experienced HYPERTENSIVE CRISIS (Had a spike in blood pressure (194/100)) (seriousness criterion medically significant), HEART RATE INCREASED (Increased heart rate), LIMB INJURY (Toe injury/Minor bruising), INSOMNIA (Trouble sleeping) and SLEEP DISORDER (Sleeping pattern has changed). At the time of the report, HYPERTENSIVE CRISIS (Had a spike in blood pressure (194/100)), HEART RATE INCREASED (Increased heart rate), LIMB INJURY (Toe injury/Minor bruising), INSOMNIA (Trouble sleeping) and SLEEP DISORDER (Sleeping pattern has changed) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Blood pressure measurement: 194/100 (High) High.         Two weeks after receiving the vaccine the patient had trouble sleeping and sleeping pattern was changed. The patient reported that she had a spike in blood pressure (194/100) and increased heart rate when she went for doctor's appointment. She has white coat syndrome. The patient was prescribed Ativan 1-2 times a week as needed (after sleeping pattern changed). The patient consumed a cup of wine to help her fall asleep. On 06-Apr-2021 or 07-Apr-2021, the patient had a toe injury which caused minor bruising and sleep problems started around that time.  Company Comment :  Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded. However, Further information has been requested.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded. However, Further information has been requested.
Got my 1st dove of vaccine on 1/12/21.i experienced pain on my L arm the following day. And felt generalized body aches. I took ibuprofen and it?s all gone the following day. But on the 3rd day I began to exoerience itchiness on one part of my body...which is my L arm. Then it began to spread all over my body. I took cetitizine in the morning for itchiness and benadryl  At night so I can sleep better. The itchiness was controlled by anti histamine but small redness/ rashes kept spreading all over my body as days goes by... the rashes and itchiness continues everyday until it becomes hives. Hydrocortisone cream or moisturizer had temporarily relief. Last night  it spreads thru my neack, ears, face and my eyes that?s why I called in and will go to urgent care or ER soon.
August menstruation lasting 2 weeks. September menstruation very light bleeding only dark blood, heavy sweets cravings, increase in range of cramps (neck to ankles). Normal menstruation is on time lasting 5-7 days with regular bleeding and moderate abdominal cramps.
Fever up to 102.1, nausea, severe headache, fatigue,  muscle pain throughout body
This spontaneous report as received from a Medical Assistant refers to an adult patient of unknown age and gender who on 13-MAY-2015 was vaccinated with an improperly stored dose of GARDASIL lot #K006960 (exp date, dose and route of administration not provided). According to the reporter the vaccine dose administered underwent a temperature excursion for 63 hours. This is one of several reports from the same reporter. Additional information is not expected as all correspondence was received. Product and narrative were updated.
Patient is a 47-year-old male who is seen in consultation for Dr. for evaluation of left arm injection site reaction. Patient states he had the influenza vaccination injection given on 10/3/18 in his proximal left upper extremity. Patient states about 2 weeks following the injection, he noticed a knot in the proximal left upper extremity. States he noticed the knot increase in size and become red and inflamed. States on 12/3/18, about 3 weeks ago, staff at Dr.'s office performed an I&D on the proximal left upper extremity lesion. States he packed it once a day for 6 days, and has been packing every other day since then. Patient reports that the wound is still draining purulent drainage. Reports that the area is tender to touch, and rates pain 3/10. States that he currently has the flu. States he has been on 2 rounds of antibiotics including BACTRIM and KEFLEX. I&D performed, cultures obtained, wet-to-dry dsg BID.